"Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men." AIDS and behavior 18, no. 2 (2014): 241-9. Abstract
"Sexual behaviour among users of antiretroviral pre-exposure prophylaxis." The Lancet infectious diseases 13, no. 12 (2013): 996-7.
"Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?" Journal of empirical research on human research ethics : JERHRE 9, no. 1 (2014): 71-82. Abstract
"Implementation science of pre-exposure prophylaxis: preparing for public use." Current HIV/AIDS reports 7, no. 4 (2010): 210-9. Abstract
"Preexposure chemoprophylaxis for HIV prevention." The New England journal of medicine 364, no. 14 (2011): 1374; author reply 1374-5.
"Legal and ethical values in the resolution of research-related disputes." Journal of empirical research on human research ethics : JERHRE 9, no. 1 (2014): 71-82. Abstract
"A Qualitative Study of Medical Mistrust, Perceived Discrimination, and Risk Behavior Disclosure to Clinicians by U.S. Male Sex Workers and Other Men Who Have Sex with Men: Implications for Biomedical HIV Prevention." Journal of urban health : bulletin of the New York Academy of Medicine (2015). Abstract
"Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: a Comment on Gamarel and Golub." Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2014).
"Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: balancing methodological rigor and research ethics." Social science & medicine (1982) 94 (2013): 115-23. Abstract
"Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States." American journal of law & medicine 38, no. 4 (2012): 607-66. Abstract
"What motivates use of community-based human immunodeficiency virus testing in rural South Africa?" International journal of STD & AIDS (2015). Abstract
"'Mobile men with money': the socio-cultural and politico-economic context of 'high-risk' behaviour among wealthy businessmen and government officials in urban China." Culture, health & sexuality 10, no. 8 (2008): 801-14. Abstract
"Identifying HIV risk-reduction strategies for Hispanic populations in Broward County." Annals of epidemiology 19, no. 8 (2009): 567-74. Abstract
"Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia." BMC public health 15, no. 1 (2015): 1255. Abstract
"Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West." AIDS (London, England) 28, no. 11 (2014): 1657-64. Abstract
"The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 6, no. 1 (2002): 23-7. Abstract
"Syphilis as a social disease: experience from the post-communist transition period in Estonia." International journal of STD & AIDS 15, no. 10 (2004): 662-8. Abstract
"Assessing non-response to a mailed health survey including self-collection of biological material." European journal of public health 21, no. 4 (2011): 538-42. Abstract
"High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs." Journal of public health (Oxford, England) 30, no. 2 (2008): 119-25. Abstract
"Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia." BMC public health 11 (2011): 517. Abstract
"Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents." International journal of STD & AIDS 13, no. 2 (2002): 79-85. Abstract
"The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia." BMC infectious diseases 13 (2013): 304. Abstract
"A decline in the prevalence of injecting drug users in Estonia, 2005-2009." The International journal on drug policy 24, no. 4 (2013): 312-8. Abstract
"Treatment of sexually transmitted diseases in Estonia: consistency with the evidence-based medicine principles." Sexually transmitted diseases 31, no. 10 (2004): 631-5. Abstract
"Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia." BMC infectious diseases 10 (2010): 63. Abstract
"HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic." PloS one 12, no. 2 (2017): e0170956. Abstract
"Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance." The Journal of infectious diseases 193, no. 3 (2006): 455-7. Abstract
"Atypical genital herpes: report of five cases." Scandinavian journal of infectious diseases 36, no. 1 (2004): 37-9. Abstract
"Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia." Journal of urban health : bulletin of the New York Academy of Medicine 87, no. 2 (2010): 304-17. Abstract
"Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries." BMC public health 14, no. 1 (2014): 1147. Abstract
"The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia." Scandinavian journal of infectious diseases 36, no. 10 (2004): 727-32. Abstract
"Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia." Sexually transmitted infections 88, no. 1 (2012): 58-62. Abstract
"High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia." International journal of STD & AIDS 18, no. 1 (2007): 41-6. Abstract
"Validation of the 'drinking expectancy questionnaire for men who have sex with men' in Peru." Drug and alcohol review (2015). Abstract
"A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment." Drug and alcohol dependence (2013). Abstract
"A systematic review of alcohol use and sexual risk-taking in Latin America." Revista panamericana de salud pública = Pan American journal of public health 34, no. 4 (2013): 267-74. Abstract
"Being Unaware of Being HIV-Infected is Associated with Alcohol Use Disorders and High-Risk Sexual Behaviors Among Men Who have Sex with Men in Peru." AIDS and behavior 18, no. 1 (2013): 120-7. Abstract
"Goals and Plans of Incarcerated Men Postrelease." Journal of correctional health care : the official journal of the National Commission on Correctional Health Care 22, no. 2 (2016): 146-56. Abstract
"A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease." Blood 118, no. 20 (2011): 5401-8. Abstract
"Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana." BMC infectious diseases 15, no. 1 (2015): 130. Abstract
"How we think they see us? Valence and difficulty of retrieval as moderators of the effect of meta-stereotype activation on intergroup orientations." International journal of psychology : Journal international de psychologie (2016). Abstract
"Effectiveness over time of varicella vaccine." JAMA : the journal of the American Medical Association 291, no. 7 (2004): 851-5. Abstract
"Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 15, no. 9 (2011): 1170-5, i. Abstract
"Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency." Toxicology and applied pharmacology 234, no. 2 (2009): 209-21. Abstract
